User profiles for Erkka Valo

Erkka Valo

Doctoral student, University of Helsinki
Verified email at helsinki.fi
Cited by 1210

[HTML][HTML] Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

…, R Louhimo, P Chen, V Aittomäki, E Valo… - Genome medicine, 2010 - Springer
Background Coordinated efforts to collect large-scale data sets provide a basis for systems
level understanding of complex diseases. In order to translate these fragmented and …

A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes

…, E Fauman, NR Robertson, PM McKeigue, E Valo… - Diabetes, 2018 - Am Diabetes Assoc
Identification of sequence variants robustly associated with predisposition to diabetic kidney
disease (DKD) has the potential to provide insights into the pathophysiological mechanisms …

Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen

…, C Qiu, V Nair, C Di Liao, JJ Cao, E Valo… - Journal of the …, 2019 - journals.lww.com
Background Although diabetic kidney disease demonstrates both familial clustering and
single nucleotide polymorphism heritability, the specific genetic factors influencing risk remain …

The genetic landscape of renal complications in type 1 diabetes

…, D Trégouët, E Dahlström, E Valo… - Journal of the …, 2017 - journals.lww.com
Diabetes is the leading cause of ESRD. Despite evidence for a substantial heritability of diabetic
kidney disease, efforts to identify genetic susceptibility variants have had limited success…

[PDF][PDF] ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression

…, P Szyniarowski, E Corcelle-Termeau, E Valo… - Molecular cell, 2012 - cell.com
Aberrant ErbB2 receptor tyrosine kinase activation in breast cancer is strongly linked to an
invasive disease. The molecular basis of ErbB2-driven invasion is largely unknown. We show …

[HTML][HTML] Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes

S Mutter, E Valo, V Aittomäki, K Nybo, L Raivonen… - Diabetologia, 2022 - Springer
Aims/hypothesis This prospective, observational study examines associations between 51
urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 …

Urinary proteomics identifies cathepsin D as a biomarker of rapid eGFR decline in type 1 diabetes

CP Limonte, E Valo, V Drel, L Natarajan… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE Understanding mechanisms underlying rapid estimated glomerular filtration
rate (eGFR) decline is important to predict and treat kidney disease in type 1 diabetes (T1D). …

Variations in risk of end-stage renal disease and risk of mortality in an international study of patients with type 1 diabetes and advanced nephropathy

J Skupien, AM Smiles, E Valo, TS Ahluwalia… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE Patients with type 1 diabetes and diabetic nephropathy are targets for intervention
to reduce high risk of end-stage renal disease (ESRD) and deaths. This study compares …

[HTML][HTML] Biomarker panels associated with progression of renal disease in type 1 diabetes

M Colombo, E Valo, SJ McGurnaghan, N Sandholm… - Diabetologia, 2019 - Springer
Aims/hypothesis We aimed to identify a sparse panel of biomarkers for improving the prediction
of renal disease progression in type 1 diabetes. Methods We considered 859 individuals …

[HTML][HTML] Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease

…, D Fermin, LJ Smyth, RM Salem, C Forsblom, E Valo… - Diabetologia, 2022 - Springer
Aims/hypothesis Diabetic kidney disease (DKD) is the leading cause of kidney failure and
has a substantial genetic component. Our aim was to identify novel genetic factors and genes …